DURECT CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.84 EUR | +3.70% |
|
-10.16% | +60.00% |
| May. 14 | Durect Far From Earnings Story But FDA Commentary Shows Path Forward, Oppenheimer Says | MT |
| May. 13 | Transcript : DURECT Corporation, Q1 2024 Earnings Call, May 13, 2024 |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DURECT CORPORATION | Bio Therapeutic Drugs | +3.70% | -10.16% | +60.00% | -82.64% | -87.20% | 29.29M | - | - | - |
- Stock Market
- Equities
- DRRX Stock
- DC8A Stock
- Charts DURECT Corporation
- Relative Strength Chart
